Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases.

Détails

ID Serval
serval:BIB_52CD25F3C9C8
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases.
Périodique
Annals of surgical oncology
Auteur⸱e⸱s
Schell F., Kefleyesus A., Benzerdjeb N., Passot G., Rousset P., Omar A., Villeneuve L., Péron J., Glehen O., Kepenekian V.
ISSN
1534-4681 (Electronic)
ISSN-L
1068-9265
Statut éditorial
Publié
Date de publication
07/2023
Peer-reviewed
Oui
Volume
30
Numéro
7
Pages
4444-4454
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Selected patients with colorectal cancer peritoneal metastasis (CRPM) and extraperitoneal disease could be treated radically with a multimodal approach combining complete cytoreductive surgery, thermoablation, radiotherapy, and systemic and intraperitoneal chemotherapy. The impact of extraperitoneal metastatic sites (EPMS) in this setting remains unclear.
Patients with CRPM undergoing complete cytoreduction in 2005-2018 were grouped in: peritoneal disease only (PDO), one EPMS (1 + EPMS), two or more EPMS (2 + EPMS). A retrospective analysis compared overall survival (OS) and postoperative outcomes.
Of 433 patients, 109 had 1 + EPMS and 31 had 2 + EPMS. Overall, 101 patients had liver metastasis, 19 lung metastasis, and 30 retroperitoneal lymph node (RLN) invasion. The median OS was 56.9 months. There was no significant OS difference between PDO and 1 + EPMS groups (64.6 and 57.9 months, respectively), whereas OS was lower in the 2 + EPMS group (29.4 months, p = 0.005). In multivariate analysis, 2 + EPMS [hazard ratio (HR) 2.86, 95% confidence interval (CI) 1.33-6.12, p = 0.007], Sugarbaker's Peritoneal Carcinomatosis Index (PCI) > 15 (HR 3.86, 95% CI 2.04-7.32, p < 0.001), poorly differentiated tumors (HR 2.62, 95% CI 1.21-5.66, p = 0.015), and BRAF mutation (HR 2.10, 95% CI 1.11-3.99, p = 0.024) were independent poor prognostic factors, while adjuvant chemotherapy was beneficial (HR 0.33, 95% CI 0.20-0.56, p < 0.001). Patients with liver resection did not show higher severe complication rates.
In patients with CRPM selected for a radical surgical approach, limited extraperitoneal disease involving one site, notably the liver, does not seem to significantly impair postoperative results. RLN invasion appeared as a poor prognostic factor in this population.
Mots-clé
Humans, Peritoneal Neoplasms/secondary, Retrospective Studies, Colorectal Neoplasms/pathology, Peritoneum/pathology, Chemotherapy, Adjuvant, Cytoreduction Surgical Procedures/adverse effects, Hyperthermia, Induced/adverse effects, Survival Rate, Combined Modality Therapy, Prognosis
Pubmed
Web of science
Création de la notice
24/03/2023 11:47
Dernière modification de la notice
19/07/2023 5:56
Données d'usage